Can a CT scan predict who will benefit from lung cancer chemoimmunotherapy?
NCT ID NCT07559123
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether features on CT scans can predict how well non-small cell lung cancer responds to chemoimmunotherapy given before surgery. Researchers will compare CT images taken before and after treatment with the actual results from surgery. The goal is to develop a noninvasive tool to guide treatment decisions and reduce unnecessary side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-resolution deep learning-based CT reconstruction
What this could lead to
If successful, this could lead to a noninvasive way to identify which lung cancer patients are most likely to benefit from chemoimmunotherapy before surgery, helping tailor treatment and avoid unnecessary side effects.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care yet. The imaging biomarkers may not prove accurate enough in larger or more diverse groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••